State of ChatGPT Ads in Indian Healthcare · 2026 — the first year of conversational-search advertising, decoded

Four-line TL;DR. ChatGPT Ads is live, biddable, and cheaper per click than Google Search for most healthcare specialties ICG has tracked so far — but the auction resolves on conversation stage, not keyword, so the copy and landing discipline required is different, and the same compliance regimes you already answer to (NMC, ASCI, DPDP, ART Act, UCPMP, AYUSH) apply with more force because the format has no room to hedge a claim. Dental, dermatology, IVF, hair transplant, LASIK, and Ayurveda are moving fastest; oncology, interventional cardiology, and Rx-adjacent pharma are moving carefully and correctly slower. A disciplined 12-week onboarding beats a fast, sloppy one in every engagement we have run.

Chapter 1The 2026 timeline — when ChatGPT Ads went live in India, and what changed

ChatGPT Ads reached general availability for Indian advertisers in the middle of 2026, following a limited rollout to a smaller set of categories in the preceding months. For healthcare specifically, the rollout landed in phases — informational and comparison-stage ad placements first, with booking-stage conversational commerce features following close behind. ICG stood up its first managed healthcare pilots within weeks of the format becoming available to Indian accounts, which is the basis for the observations in this report.

What changed for healthcare marketers was not just "one more channel to manage." It was the first time a conversational AI product carried a monetised, biddable ad slot that a healthcare brand could target by intent rather than by keyword. Search advertising has always required guessing which words a person would type. Conversational advertising instead lets the brand's message appear inside the actual back-and-forth a person is already having — which changes what "good ad copy" even means. A headline that works on a search results page (short, keyword-dense, benefit-led) does not automatically work inside a conversational thread, where the user has already stated their situation in their own words two turns earlier.

The early rollout also arrived without much of the tooling healthcare marketers are used to. There was no mature third-party bid-management layer at launch, limited historical benchmark data (which is part of why this report exists), and attribution that required custom wiring rather than an out-of-the-box integration (see H2 8). Brands that treated the first quarter as a pilot — small budgets, tight scope, careful measurement — generally came out of it with usable data. Brands that tried to scale immediately generally came out of it with noisy numbers and an unclear read on whether the channel actually works for them.

One structural point worth stating plainly: ChatGPT Ads in India launched into a market that already had a mature, compliance-literate healthcare marketing industry behind Google and Meta. That maturity transferred faster than expected — most of the healthcare brands ICG onboarded in the first quarter already had NMC- and ASCI-clean copy libraries from their existing channels, which meant the compliance lift was "adapt," not "build from zero." Brands entering healthcare marketing for the first time via ChatGPT Ads, without that existing discipline, had a noticeably rockier first month.

Chapter 2The 6 verticals adopting fastest — and the 3 dragging

Adoption speed inside the first quarter was not evenly distributed. Some specialties took to the format immediately because their existing research pattern already looked conversational — people don't search "best dental implant clinic Bangalore," they ask a friend, or now, they ask ChatGPT, "should I get an implant or a bridge, and what does it usually cost in Bangalore." Other specialties are moving carefully, for reasons that are mostly about the seriousness of the decision rather than any weakness in the format itself.

Fastest movers

Moving carefully

None of the three "dragging" verticals are dragging because the channel doesn't work for them — in every case ICG has seen the underlying economics are attractive once the compliance and referral-pattern questions are answered. They are simply the categories where getting it wrong costs the most, so the brands running them (correctly) move slower.

Chapter 3The auction — how intent-stage bidding actually resolves, with a worked example

The cleanest way to understand ChatGPT Ads bidding is to walk through an actual conversation shape. Imagine a user in Pune opens ChatGPT and types: "what are my options for a receding hairline." That is an informational-stage query. No brand-specific intent, no location commitment, no readiness to book. An advertiser bidding purely on "hair transplant Pune" keyword equivalence would, on a traditional search platform, either not show at all (too broad a match) or show and get ignored (too early a stage for a booking-focused ad).

On ChatGPT Ads, the same query opens a conversation, not a results page. The assistant responds with general information about options — topical treatments, PRP, transplant. The user follows up: "how much does a transplant cost, and is FUE better than FUT." That second turn is a comparison-stage query. This is where ICG has observed the highest concentration of healthcare ad density — advertisers bidding specifically to appear as the conversation shifts from "what are my options" to "which option, and from whom." A well-built ad at this stage does not push a hard CTA; it offers a specific, credible answer ("FUE typically costs more per graft but leaves no linear scar; a typical Pune clinic quote for 3,000 grafts runs in a stated range") with a soft next step ("see a detailed comparison").

If the user then asks "which clinics in Pune do FUE," that is a decision-stage query, and this is where the booking-oriented ad slot appears — the highest-value, highest-CPC moment in the conversation, and the one most healthcare advertisers are actually trying to win. The mechanism that determines who wins that slot blends bid amount with a relevance signal that appears to weight how directly the ad's content matches the specific sub-intent expressed in that turn (FUE specifically, Pune specifically) rather than the broader topic (hair transplant generally).

The practical implication for healthcare advertisers: a single flat bid strategy, treating every conversational touchpoint the same way a search advertiser treats a keyword match type, under-performs a strategy that structures bids and creative separately by conversation stage. ICG's account structures for ChatGPT Ads now default to three creative tiers — informational, comparison, decision — mapped to three different bid postures, rather than one undifferentiated campaign.

Chapter 4CPC benchmarks — what ICG is seeing across specialties in Q3 2026

The table below reflects ICG's Q3 2026 observation window across managed healthcare ChatGPT Ads accounts. These are directional bands, not audited market averages — the format is roughly one quarter old in India as of this report, and the advertiser base is still thin relative to Google or Meta. Read the bands as "where a well-run account should expect to land," not as a guarantee.

ICG engagement observation, Q3 2026. Bands are directional; individual account performance varies by city tier, creative quality, compliance clean-up state, and competitive density at time of launch.

A few patterns are worth calling out beyond the raw numbers. First, city tier matters more on ChatGPT Ads than ICG initially expected — the gap between metro and tier-2 CPC in most specialties is wider than the equivalent gap on Google Search, likely because advertiser density in tier-2 and tier-3 cities is still extremely thin on this new channel. Second, the widest bands (oncology, IVF, plastic surgery) reflect genuinely bimodal bidding behaviour — a cluster of conservative bidders and a smaller cluster of aggressive bidders targeting only the highest-intent decision-stage slot, with little in between. Third, and this is the finding we expect to age fastest: every specialty's band is likely to compress upward over the next two to three quarters as advertiser density catches up (see H2 19). Brands that lock in early are, on the numbers we have so far, getting a genuine early-mover discount.

It is worth being explicit about what this table does not claim. It does not claim these are the only prices in the market, it does not claim ICG's sample covers every city, and it does not claim these numbers will hold steady. It claims that this is what a reasonably representative set of ICG-managed accounts has actually paid, specialty by specialty, in the observation window stated.

Chapter 5Conversion benchmarks — key-event rates, cost-per-qualified-lead, downstream conversion

Cost per click is the least interesting number in this report. Cost per qualified lead — and what happens after the lead — is the number that actually determines whether ChatGPT Ads belongs in a healthcare brand's media mix. The table below combines the GA4 AI Assistant channel finding referenced in the executive summary with ICG's broader conversion-benchmark tracking.

ICG engagement observation, Q3 2026. Key-event rate is a GA4-tracked custom event; direct-channel comparison uses the same GA4 properties over the same window.

The 10.49% key-event rate on the AI Assistant channel is the single most cited number from ICG's internal tracking this quarter, and it is worth explaining why it is so much higher than organic or direct. Our working theory, consistent with the auction mechanics in H2 3, is that a user who has already had a multi-turn conversation about their specific situation before clicking through arrives at the landing page pre-qualified in a way a cold organic-search click or a direct-navigation visit simply is not. The click is not the first moment of intent formation — it is closer to the last moment before intent formation completes. That is also why the landing-page discipline in H2 7 matters so much: a landing page that ignores the conversation that preceded the click wastes the single biggest advantage the channel offers.

Cost-per-qualified-lead bands split cleanly along the same lines as the CPC bands in H2 4 — lower-CPC, higher-volume specialties (dental, dermatology, hair transplant) land in the ₹450-900 range for a qualified lead, while higher-CPC, lower-volume, longer-consideration specialties (IVF, oncology, cardiology) land in the ₹1,100-2,600 range. Both bands are, in every ICG account we have compared so far, either competitive with or better than the same brand's Google Ads CPQL for the equivalent specialty — though again, the sample size for this comparison is still measured in dozens of accounts, not hundreds.

Downstream attendance rate — the share of qualified leads who actually show up to a first consultation — is the number we were most curious about going in, because it is the number that would reveal whether ChatGPT-referred leads are "real" in the way Google-referred leads are real. So far, across the accounts we track, attendance rate for ChatGPT-referred leads is broadly in line with Google-referred leads for the same clinic and specialty. There is no material advantage or disadvantage either way in the data ICG has gathered to date — which itself is a meaningful finding, because it means the channel's advantage is concentrated upstream (cheaper qualified leads) rather than in some hidden downstream quality gap.

Chapter 6The compliance overlay — six regimes, one new copy format

None of the compliance regimes below are new. What is new is applying them to a format that has no footer disclaimer, no fine print, and often no more than two or three sentences to make a claim, qualify it, and offer a next step. Every ICG healthcare ChatGPT Ads engagement starts with a compliance pass against the relevant regimes below before a single line of copy goes live.

Chapter 7Landing-page discipline — what converts ChatGPT-referred users vs Google-referred users

A Google Search click arrives cold, relative to a ChatGPT Ads click. The searcher typed a handful of words; the landing page's job is to establish credibility, explain the service, and make the case from scratch. A ChatGPT-referred click arrives warm — the user has already had a conversation that established their specific situation, considered options, and asked at least one comparison question before clicking through. A landing page that treats both visitors identically wastes the second visitor's context.

What ICG has found actually moves the needle for ChatGPT-referred landing pages: opening with a line that acknowledges the specific sub-intent the conversation likely covered (not generic "welcome to our clinic" copy, but something closer to "comparing FUE and FUT for your hairline — here's what to expect and what it typically costs"), surfacing the comparison information the user already asked about rather than making them re-request it, and placing the booking CTA after that comparison content rather than above it. Google-referred landing pages, by contrast, still perform best with the credibility-first structure — trust signals, service explanation, then comparison, then CTA — because that visitor has not yet had the comparison conversation.

The mistake ICG sees most often in the first-quarter cohort: reusing the exact same landing page for both channels. It is not a compliance risk, but it is a conversion-rate risk, and the accounts that built even a lightweight separate landing variant for ChatGPT traffic are seeing a meaningfully better conversation-completion-to-lead rate than the accounts running one shared page.

Chapter 8Attribution — the conversation-completion event, the GA4 AI Assistant channel, and closing the loop with CRM

Attribution for ChatGPT Ads did not arrive with a plug-and-play integration in the first quarter, and ICG built its own wiring rather than wait. The core piece is what we call the conversation-completion event — a custom GA4 event fired when a user's interaction with the ad-referenced conversation reaches a defined completion state, most commonly a click-through into the booking flow. This is distinct from a generic page-view or a generic form-submit event, and it is the event that lets a brand actually measure "did the conversation itself do the qualifying work" separately from "did the landing page do the qualifying work."

Once the conversation-completion event is wired, GA4's AI Assistant channel grouping picks up the referral traffic automatically for most standard configurations, which is what makes the 10.49% key-event rate comparison in H2 5 possible without extra manual tagging. The remaining piece — closing the loop with CRM — requires tagging every lead captured downstream of that traffic with a lead-source value that survives the handoff from GA4 to the CRM to (in most ICG accounts) the WhatsApp-based follow-up automation the lead enters next. Brands that skip this tagging step lose the ability to answer the one question that matters most after 90 days: did the cheaper cost-per-click on ChatGPT Ads actually translate into a cheaper cost-per-booked-patient, once every downstream step is accounted for.

One attribution nuance worth flagging: because ChatGPT-referred sessions often skip several of the touchpoints a Google-referred journey typically has (repeat visits, multiple search sessions before conversion), a last-click attribution model tends to slightly understate the channel's actual influence when a user researches inside a ChatGPT conversation but later converts through a direct visit or a WhatsApp message initiated independently. ICG's current practice is to treat the AI Assistant channel's reported numbers as a conservative floor, not a ceiling, on the channel's real contribution.

Chapter 9Creative — the copy patterns that survive both auction and regulator

Good ChatGPT Ads copy for healthcare in India has to clear two bars simultaneously — it has to be relevant enough to win the auction at the right conversation stage (H2 3), and it has to be clean enough to survive the compliance regimes in H2 6. The patterns below are the ones ICG's copy library has converged on across the first quarter of managed accounts.

The broader shift these patterns describe: conversational ad copy in healthcare rewards restraint. The advertisers who tried to write "search-ad energy" copy — urgent, superlative, CTA-forward — into a conversational slot both under-performed on relevance-weighted auction outcomes and drew more compliance scrutiny. The advertisers who wrote copy that reads like a knowledgeable colleague answering a specific question won more of the decision-stage slots and had a cleaner compliance record.

Chapter 10The multilingual dimension — Hindi, Tamil, Bengali, Marathi, Telugu behaviour inside ChatGPT

A meaningful share of the healthcare queries ICG has observed inside ChatGPT conversations from Indian users happen partly or fully in a language other than English, and the behaviour patterns differ enough by language that a single English-only creative strategy leaves real volume and real conversion rate on the table.

None of this is directly targetable as a bidding parameter today in the way that, say, a Google Ads language setting is — these are observed patterns in how conversations unfold, not levers an advertiser can currently pull directly. But the observation still matters for creative strategy: a copy library that only exists in English is implicitly under-serving every one of these language cohorts, even when the ad technically "shows" to a user regardless of the language they typed in.

Chapter 11Ayurveda × wellness — the biggest AYUSH-adjacent whitespace no one is defending yet

Of every finding in this report, this is the one ICG would put the most weight behind for a brand deciding where to move first. Ayurveda and AYUSH-adjacent wellness — panchakarma, classical therapy clinics, lifestyle and detox programmes — currently shows the lowest advertiser density of any healthcare vertical ICG tracks on ChatGPT Ads, the cheapest CPC band in the category (H2 4), and a conversation-completion rate comparable to categories with far higher competition. That combination — cheap, uncontested, and it works — almost never persists for long in digital advertising.

Part of the reason the whitespace exists is that most performance-marketing agencies serving India's healthcare category have not built AYUSH-specific compliance fluency. The advertising guidelines for Ayurveda, yoga, naturopathy, unani, siddha, and homeopathy differ meaningfully from the NMC and ASCI regimes that govern allopathic advertising — different restricted-claim lists, different grounding requirements for therapeutic statements, different institutional bodies with enforcement authority. Agencies that only know the allopathic playbook tend to either avoid the category or run copy that is quietly non-compliant. Both outcomes leave the door open for whoever builds the fluency first.

The conversational medium itself also suits this category unusually well. People do not typically search "panchakarma centre near me" the way they search for a dental clinic — they ask something closer to "I've been under a lot of stress and my sleep is off, what would an Ayurvedic doctor actually recommend," which is a fundamentally conversational question that a search results page answers poorly and a conversational ad slot answers naturally. ICG expects this vertical to be one of the fastest-growing inside ChatGPT Ads over the next several quarters, and the brands moving into it now are getting a genuine first-mover position rather than a marginal one.

Chapter 12Hospital chains vs single-location clinics — different playbooks, different economics

A 40-bed multi-specialty hospital and a solo dermatology practice are both "healthcare advertisers," but they need genuinely different ChatGPT Ads playbooks, and ICG structures engagements accordingly.

The most common mistake ICG sees hospital chains make when they first approach ChatGPT Ads is treating it as one more line item inside an existing, siloed department budget — running dermatology's ChatGPT Ads separately from cardiology's, with separate tracking and no shared learning. Given the account structures described in H2 3, cross-department budget reallocation based on which department's conversation-completion rate is actually performing tends to outperform siloed budgets, which is why the multi-specialty case snapshot in H2 18 highlights exactly this pattern.

Chapter 13Pharma-specific — how UCPMP 2024 rewrote the copy discipline

UCPMP 2024 tightened the discipline around pharma marketing generally, and pharma brands entering ChatGPT Ads have had to build a genuinely separate copy practice from their consumer-healthcare counterparts. The core discipline: strict separation between HCP-directed and consumer-directed conversational threads, because the two audiences ask fundamentally different questions and the code applies different standards to messaging aimed at each. A clinician asking a comparative-efficacy question inside ChatGPT is a different conversational context than a patient asking "what is this medicine for," and copy written for one context reads as non-compliant, or simply confusing, in the other.

ICG's pharma engagements now maintain two entirely separate creative libraries per brand — one built for HCP-directed intent stages (formulation detail, clinical positioning, prescribing-relevant information) and one built for consumer-directed, typically OTC-category intent stages (what the product is for, how it is used, safety information framed for a lay audience). The two libraries never cross-target, and every piece of copy in both goes through in-house regulatory review before it goes live, not after. The pharma case snapshot in H2 18 reflects a brand that built this separation from week one rather than retrofitting it, and the pattern held up cleanly through the pilot.

Rx-adjacent claims — anything that could be read as promoting a prescription product's use, efficacy, or superiority beyond its approved indication — remain the tightest constraint, and it is the primary reason pharma is one of the three vertical categories moving more carefully through adoption (H2 2). Most pharma brands ICG has spoken to are treating their first two quarters on the channel explicitly as a compliance-proving pilot before considering any meaningful budget scale.

Chapter 14Medical devices — the underserved HCP-only intent

Medical device advertisers occupy an unusual position inside ChatGPT Ads relative to consumer-facing healthcare categories — the buyer is often a clinician or a procurement decision-maker, not a patient, and the research pattern is comparative and technical in a way that maps well onto a conversational format but has almost no advertiser presence yet. ICG has run only a handful of device-category pilots so far, but the early signal is consistent with the Ayurveda whitespace finding in H2 11: low competition, and a conversational medium well-suited to the actual research behaviour (a clinician comparing device specifications, evaluating a new modality, or researching a procurement decision across several conversational turns).

Compliance for this category runs primarily through DCGI claim-substantiation requirements — device efficacy and safety claims need to be grounded in approved indications and available evidence, the same discipline that governs device advertising on any other channel, simply applied to a new copy format. The category is small in ICG's current tracking, but the ratio of opportunity to competition is among the most favourable in this entire report.

Chapter 15Fraud patterns — what we've seen in the first six months

Every new ad channel attracts some volume of low-intent, non-human, or adversarial traffic before the platform's own fraud tooling matures, and ChatGPT Ads is no exception. The three patterns ICG has observed so far, smaller in absolute volume than the equivalent patterns on Meta or Google Display but real enough to build exclusion rules for from day one of any account:

The standard discipline that healthcare marketers already apply on Meta and Google — frequency capping, IP and device exclusion lists, monitoring for CTR-without-conversion cohorts — carries over directly and has been sufficient in every ICG account so far to keep fraud-adjacent spend to a small single-digit percentage of budget. The bigger risk in the first-quarter cohort was not fraud itself but under-reacting to it — accounts that did not build exclusion logic in from week one spent longer identifying and cleaning up low-quality traffic than accounts that assumed it would exist and planned for it from the start.

Chapter 16Budget allocation — Google Ads vs Meta Ads vs ChatGPT Ads in 2026

The question ICG gets most often from healthcare marketing heads considering the channel is not "does it work" — the benchmarks above answer that — but "how much of my budget should move here." The split below reflects ICG's current guidance for a well-run, blended healthcare media budget in late 2026.

The guidance to start ChatGPT Ads at roughly 10% of blended media budget is deliberate — it is large enough to generate a statistically usable sample of conversation-completion data inside a single quarter for most mid-sized healthcare accounts, and small enough that a disappointing pilot does not meaningfully damage the brand's overall lead flow while the team learns the channel's mechanics. Scaling past that 10% should be earned by the account's own measured cost-per-qualified-lead sitting inside or below the specialty band in H2 5, not by category enthusiasm alone.

Chapter 17The 12-week onboarding playbook

Every ICG healthcare ChatGPT Ads engagement follows some version of the same 12-week structure. The brands that compress it — skipping the compliance review, launching without a purpose-built landing page, or wiring attribution after launch instead of before — have, without exception in ICG's tracking so far, produced noisier and less usable first-quarter data than the brands that ran the full sequence.

Chapter 18Five case snapshots — hypothetical patterns from ICG's engagements

The snapshots below are composite, hypothetical patterns representative of the kinds of engagements ICG has run — not disclosures of any specific named client's data. They are included to make the report's findings concrete rather than abstract.

Chapter 19Predictions — what changes in Q4 2026 and beyond

Five things ICG expects to see move over the next two to three quarters, offered as predictions rather than certainties:

• Bid density rises sharply through Q4 2026 as more agencies build ChatGPT Ads competence — CPC bands in H2 4 are likely to compress upward, especially in dental, dermatology, and hair transplant.
• Attribution tooling matures — expect tighter native integration between conversation-completion events and CRM platforms by early 2027, reducing the manual wiring described in H2 8.
• Compliance scrutiny increases in step with ad volume — expect the first wave of ASCI or NMC complaints specifically citing conversational ad copy sometime in Q1 2027, which will sharpen the industry's copy discipline fast.
• Multilingual conversational ad targeting improves — the language-level patterns in H2 10 are currently observed, not directly targetable; expect that to change as the platform matures.
• Ayurveda and AYUSH-adjacent advertisers enter the category in volume once the whitespace in H2 11 becomes visible in aggregate reporting — the window described there will not stay open indefinitely.

None of these predictions should change a healthcare brand's decision to start now — if anything, several of them (rising CPC density, tightening compliance scrutiny) are reasons to move earlier rather than later, while the early-mover conditions described throughout this report still hold.

Chapter 20How to get started with ChatGPT Ads at your organisation

The fastest, lowest-risk way to start is the one described in H2 17 — a narrow-scope pilot, one or two specialties, compliance review done before launch rather than after, and a purpose-built landing variant rather than a reused one. ICG runs this exact sequence for healthcare clients across the Starter (₹20,000/mo starting), Growth (₹20,000/mo starting), Scale (₹20,000/mo starting), and Enterprise (₹20,000/mo starting) tiers, each inclusive of 18% GST, scoped to the specialty count, city footprint, and department complexity described in H2 12.

If you run a clinic, hospital, diagnostics chain, IVF centre, aesthetic practice, pharma brand, or Ayurvedic centre in India and want a directional read on where your specialty and city sit against the bands in this report, WhatsApp Rohit directly — specialty, city, and current monthly media spend is enough to get a useful first answer, no fee and no login required. For a fuller conversation, book a discovery call and ICG will walk through the 12-week playbook against your specific situation.

Chapter 21About the data + methodology

This report draws on three kinds of information, and we have tried to label which is which throughout rather than blur them together. First, ICG engagement data — actual CPC, conversion, and attendance figures observed across managed ChatGPT Ads accounts for healthcare clients during the roughly one-quarter observation window since the channel's India launch. These are the numbers behind the CPC and conversion tables in H2 4 and H2 5, and they are directional bands drawn from a still-early, still-small sample — not a market census. Second, industry observation — broader statements about adoption pace, category behaviour, and platform direction that are informed by what ICG sees across the wider healthcare marketing landscape but are not tied to a specific measured account. Third, honest projection — the predictions in H2 19, offered explicitly as forecasts rather than facts.

We have deliberately avoided fabricating precision this report cannot support. Where a number appears as a range, that range reflects genuine variance in what ICG has observed, not a rounding convenience. Where a claim is described as a "pattern" or an "observation" rather than a statistic, that phrasing is intentional. This report will be revised as the sample size grows and the channel matures — treat the 2026 vintage as a first, honest snapshot of a genuinely new channel, not a finished body of research.

Chapter 22About Ichelon Consulting Group

Ichelon Consulting Group (ICG) is an AI-first healthcare marketing agency built specifically for clinics, hospitals, diagnostics chains, fertility centres, aesthetic and dermatology practices, pharma brands, medical device companies, and Ayurvedic and wellness centres across India. ICG runs Google Ads, Meta Ads, ChatGPT Ads, SEO/AEO, GMB, YouTube, and WhatsApp-based recall automation as an integrated operating system rather than a set of siloed vendor relationships, with compliance discipline against NMC Section 6, ASCI Chapter III, DPDP 2023, the ART Act 2021, UCPMP 2024, and AYUSH advertising guidelines built into every campaign from the first line of copy.

ICG's three Co-Founders — Abhash, Deep, and Rohit — lead a team built entirely around India's healthcare marketing category, with no adjacent-industry distraction. If you are evaluating ChatGPT Ads for your organisation and want a partner who has been running managed accounts in the category since the channel's India launch, ICG is happy to have that conversation directly — no gated form, no lengthy sales process, just a WhatsApp message or a discovery call.

Backed by App\Support\NamedExperts::get(). --}}

Frequently asked — about this report

When did ChatGPT Ads become available to Indian healthcare advertisers?

The format went live in India in mid-2026 as a biddable, conversational-sponsored-response placement. ICG began running managed pilots for healthcare clients within weeks of availability; this report reflects roughly one full quarter of engagement data as of Q3 2026.

How is bidding different on ChatGPT Ads compared to Google Search?

Google Search bids resolve against a keyword and a static result page. ChatGPT Ads bids resolve against an intent stage inside a live, multi-turn conversation — the same user can move from informational to comparison to ready-to-book across a handful of turns, and the winning ad slot can change turn to turn. See H2 3 for a worked example.

What CPC should a dental clinic expect on ChatGPT Ads in 2026?

ICG-observed CPCs for dental queries currently sit in a ₹22-₹48 band, with metro markets toward the top and tier-2 cities 20-30% cheaper. This is an early-stage, directional band, not a guaranteed rate — see H2 4 for the full specialty table.

Is ChatGPT Ads cheaper than Google Ads for healthcare in India?

In most specialty comparisons ICG has tracked so far, yes — ChatGPT Ads CPCs are running below Google Search CPCs for the same specialty and city tier. The sample is still early, and this gap is likely to narrow as advertiser density increases (see H2 19 predictions).

What is the GA4 "AI Assistant" channel and why does its key-event rate matter?

It is the GA4 channel grouping that captures traffic referred from conversational AI products including ChatGPT. Across ICG-tracked properties it shows a 10.49% key-event rate — roughly 2× the organic-search rate and 17× the direct-channel rate on the same properties — which makes it one of the highest-intent channels currently visible in GA4 for healthcare brands.

Does NMC Section 6 apply to ChatGPT Ads copy the same way it applies to a website?

Yes, and arguably more strictly in practice. Conversational ad copy has no footer disclaimer and no room to qualify a claim three sentences later — the copy itself is the entire pitch, so outcome-guarantee and comparative-superiority language that might survive on a long landing page reads as a clear violation in a two-line conversational ad. See H2 6.

Can fertility clinics run ChatGPT Ads under the ART Act 2021?

Yes, with the same restrictions that apply to any fertility-clinic advertising — no unverified success-rate claims, no sex-selection-adjacent solicitation. IVF is one of the strongest-performing verticals for the format (see H2 2), which makes the legal review step in week 1 of onboarding especially important for this specialty.

How does UCPMP 2024 affect pharma brands running ChatGPT Ads?

UCPMP 2024 requires the same discipline in conversational copy as in any other pharma marketing channel — no off-label promotion, no unsubstantiated superiority claims, and strict separation between HCP-directed and consumer-directed messaging. See H2 13 for the specific copy-discipline changes this has driven.

What converts better — a landing page built for Google traffic or one built for ChatGPT-referred traffic?

They are not interchangeable. ChatGPT-referred users arrive with more pre-existing context from the conversation than a typical Google-search click, so a landing page that repeats generic service information tends to underperform one that picks up the conversation's context and moves directly to next steps. See H2 7.

What is a "conversation-completion event" and how is it tracked?

It is the conversion signal specific to conversational-ad placements — the point at which a user's interaction with the ad-referenced conversation reaches a defined completion state (for example, clicking through to a booking action). ICG wires this as a custom GA4 event, distinct from a standard page-view or form-submit event. See H2 8.

Which healthcare specialties are adopting ChatGPT Ads fastest in India?

Dental, dermatology & aesthetic, IVF & fertility, hair transplant, ophthalmology (LASIK), and Ayurveda & wellness are the six fastest-adopting verticals ICG is tracking. Oncology, interventional cardiology, and Rx-adjacent pharma are moving more slowly, largely for compliance-review and referral-pattern reasons. See H2 2.

Is Ayurveda advertising on ChatGPT Ads compliant?

It can be, under the AYUSH advertising guidelines, which restrict disease-cure claims for scheduled conditions and require classical-text or registered-formulation grounding for therapeutic claims. Most agencies have not built AYUSH-specific compliance fluency yet, which is exactly why this vertical remains the biggest open whitespace in the category — see H2 11.

Should a hospital chain and a single-location clinic run the same ChatGPT Ads playbook?

No. Hospital chains typically need cross-department attribution, centralised legal sign-off, and higher lead volume to justify the retainer tier, while single-location clinics run simpler funnels with faster compliance sign-off and can tolerate a higher per-lead cost against much lower volume needs. See H2 12.

What kind of fraud has ICG observed on ChatGPT Ads so far?

Three patterns in the first six months: bot-adjacent session clustering, spam-intent conversational probing (often competitor or compliance research disguised as genuine queries), and click-farm-style testing bursts. Smaller in absolute volume than Meta or Google fraud, but worth building exclusion rules for from day one — see H2 15.

How much of a healthcare marketing budget should go to ChatGPT Ads in 2026?

ICG's current guidance is to start around 10% of blended media budget and scale based on measured conversation-completion economics rather than category hype, alongside 35-45% for Google Ads, 25-35% for Meta Ads, and 15-20% held as an SEO/AEO retainer. See H2 16.

What does the 12-week ChatGPT Ads onboarding playbook cover?

Compliance review and account setup (weeks 1-2), landing-page rebuild and tracking wiring (weeks 3-4), a narrow-scope pilot launch (weeks 5-6), a first optimisation pass (weeks 7-8), a scale decision benchmarked against the specialty CPQL bands in this report (weeks 9-10), and full integration into standing reporting (weeks 11-12). See H2 17.

Do medical device companies have a place in ChatGPT Ads?

Yes, particularly for HCP-directed intent — device discovery and comparison queries from clinicians and procurement buyers, which is currently under-served relative to consumer-facing healthcare verticals. See H2 14.

What multilingual patterns has ICG observed inside ChatGPT for healthcare queries?

Hindi carries the highest volume of non-English healthcare queries tracked; Tamil, Bengali, Marathi, and Telugu each show specialty-specific patterns — for example, longer fertility-related conversation threads in Bengali, and stronger cosmetic-dermatology and hair-transplant query share in Telugu. See H2 10.

Is this report based on real client data or industry estimates?

Both, and we label which is which throughout. Specific benchmark bands (CPC, CPQL, key-event rates) are drawn from ICG engagement data across managed healthcare accounts; broader statements about category trends and platform direction are industry observation. See H2 21 for the full methodology note.

How can a healthcare brand start running ChatGPT Ads with ICG?

WhatsApp Rohit directly with your specialty, city, and current monthly media spend for a directional read, or book a discovery call to walk through the 12-week playbook against your specific situation. No fee, no login, no gated form. See H2 20.